Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
| Autor: | R. Choura, H. Lajmi, K.B. Mansour, W. Hmaied, Z. Chelly |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
genetic structures Glaucoma Cornea Punctate keratitis Ophthalmology medicine Humans Ocular Surface Disease Index Blepharitis Pathological business.industry medicine.disease eye diseases medicine.anatomical_structure Cross-Sectional Studies Tears Corneal neovascularization Dry Eye Syndromes sense organs Eyelid Ophthalmic Solutions business Benzalkonium Compounds Ocular surface |
| Zdroj: | Journal francais d'ophtalmologie. 44(9) |
| ISSN: | 1773-0597 |
| Popis: | PURPOSE Our goal was to identify factors that may influence the OSDI score, in particular, ocular surface damage in patients on preserved glaucoma eye drops. METHODS This was a cross-sectional study of 155 glaucoma patients treated with preserved glaucoma eye drops. They all completed the "Ocular Surface Disease Index" (OSDI) questionnaire and underwent complete ophthalmological examination with precise evaluation of the status of the ocular surface. The assessment included Shirmer I testing, tear break up time (TBUT), eyelid, conjunctival and corneal examination with fluorescein and lissamine green staining. We analyzed factors that may influence the OSDI score and its relationship with the biomicroscopic signs. RESULTS Benzalkonium chloride (BAK) was used in 80% of cases. The OSDI score was≥13 in 61.3% of cases and classified as severe in 22.6% of cases. The biomicroscopic signs of ocular surface disease were at least minimal in 87.1% of cases. The severity of the OSDI score was statistically associated with patient age (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|